282 related articles for article (PubMed ID: 27242198)
1. The role of disulfide-bridge on the activities of H-shape gemini-like cationic lipid based siRNA delivery.
Ma XF; Sun J; Qiu C; Wu YF; Zheng Y; Yu MZ; Pei XW; Wei L; Niu YJ; Pang WH; Yang ZJ; Wang JC; Zhang Q
J Control Release; 2016 Aug; 235():99-111. PubMed ID: 27242198
[TBL] [Abstract][Full Text] [Related]
2. Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer.
Yu MZ; Pang WH; Yang T; Wang JC; Wei L; Qiu C; Wu YF; Liu WZ; Wei W; Guo XY; Zhang Q
Eur J Pharm Sci; 2016 Sep; 92():39-48. PubMed ID: 27355138
[TBL] [Abstract][Full Text] [Related]
3. Lipid-based nanoparticles in the systemic delivery of siRNA.
Lin Q; Chen J; Zhang Z; Zheng G
Nanomedicine (Lond); 2014 Jan; 9(1):105-20. PubMed ID: 24354813
[TBL] [Abstract][Full Text] [Related]
4. Effect of hydrophobic tails of plier-like cationic lipids on nucleic acid delivery and intracellular trafficking.
Pengnam S; Plainwong S; Patrojanasophon P; Rojanarata T; Ngawhirunpat T; Radchatawedchakoon W; Niyomtham N; Yingyongnarongkul BE; Opanasopit P
Int J Pharm; 2020 Jan; 573():118798. PubMed ID: 31759106
[TBL] [Abstract][Full Text] [Related]
5. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery.
Gao LY; Liu XY; Chen CJ; Wang JC; Feng Q; Yu MZ; Ma XF; Pei XW; Niu YJ; Qiu C; Pang WH; Zhang Q
Biomaterials; 2014 Feb; 35(6):2066-78. PubMed ID: 24315577
[TBL] [Abstract][Full Text] [Related]
6. Self-assembly cationic nanoparticles based on cholesterol-grafted bioreducible poly(amidoamine) for siRNA delivery.
Chen CJ; Wang JC; Zhao EY; Gao LY; Feng Q; Liu XY; Zhao ZX; Ma XF; Hou WJ; Zhang LR; Lu WL; Zhang Q
Biomaterials; 2013 Jul; 34(21):5303-16. PubMed ID: 23570718
[TBL] [Abstract][Full Text] [Related]
7. Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy.
Zheng C; Zheng M; Gong P; Deng J; Yi H; Zhang P; Zhang Y; Liu P; Ma Y; Cai L
Biomaterials; 2013 Apr; 34(13):3431-8. PubMed ID: 23375952
[TBL] [Abstract][Full Text] [Related]
8. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
[TBL] [Abstract][Full Text] [Related]
9. Self-assembly nanomicelles based on cationic mPEG-PLA-b-Polyarginine(R15) triblock copolymer for siRNA delivery.
Zhao ZX; Gao SY; Wang JC; Chen CJ; Zhao EY; Hou WJ; Feng Q; Gao LY; Liu XY; Zhang LR; Zhang Q
Biomaterials; 2012 Oct; 33(28):6793-807. PubMed ID: 22721724
[TBL] [Abstract][Full Text] [Related]
10. Regulating intracellular fate of siRNA by endoplasmic reticulum membrane-decorated hybrid nanoplexes.
Qiu C; Han HH; Sun J; Zhang HT; Wei W; Cui SH; Chen X; Wang JC; Zhang Q
Nat Commun; 2019 Jun; 10(1):2702. PubMed ID: 31221991
[TBL] [Abstract][Full Text] [Related]
11. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
[TBL] [Abstract][Full Text] [Related]
12. Polyarginine-Mediated siRNA Delivery: A Mechanistic Study of Intracellular Trafficking of PCL-R15/siRNA Nanoplexes.
Zhang HT; Yu M; Niu YJ; Liu WZ; Pang WH; Ding J; Wang JC
Mol Pharm; 2020 May; 17(5):1685-1696. PubMed ID: 32191042
[TBL] [Abstract][Full Text] [Related]
13. Redox-sensitive dendrimersomes assembled from amphiphilic Janus dendrimers for siRNA delivery.
Du XJ; Wang ZY; Wang YC
Biomater Sci; 2018 Jul; 6(8):2122-2129. PubMed ID: 29901676
[TBL] [Abstract][Full Text] [Related]
14. Selective modification of HK peptides enhances siRNA silencing of tumor targets in vivo.
Chou ST; Leng Q; Scaria P; Woodle M; Mixson AJ
Cancer Gene Ther; 2011 Oct; 18(10):707-16. PubMed ID: 21818135
[TBL] [Abstract][Full Text] [Related]
15. siRNA delivery into tumor cells by cationic cholesterol derivative-based nanoparticles and liposomes.
Hattori Y; Hara E; Shingu Y; Minamiguchi D; Nakamura A; Arai S; Ohno H; Kawano K; Fujii N; Yonemochi E
Biol Pharm Bull; 2015; 38(1):30-8. PubMed ID: 25744455
[TBL] [Abstract][Full Text] [Related]
16. Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery.
Chen G; Wang Y; Xie R; Gong S
J Control Release; 2017 Aug; 259():105-114. PubMed ID: 28159516
[TBL] [Abstract][Full Text] [Related]
17. Elucidation of the physicochemical properties and potency of siRNA-loaded small-sized lipid nanoparticles for siRNA delivery.
Sato Y; Note Y; Maeki M; Kaji N; Baba Y; Tokeshi M; Harashima H
J Control Release; 2016 May; 229():48-57. PubMed ID: 26995758
[TBL] [Abstract][Full Text] [Related]
18. A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo.
Sato Y; Hatakeyama H; Sakurai Y; Hyodo M; Akita H; Harashima H
J Control Release; 2012 Nov; 163(3):267-76. PubMed ID: 23000694
[TBL] [Abstract][Full Text] [Related]
19. Cancer-targeted MDR-1 siRNA delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance.
Yhee JY; Song S; Lee SJ; Park SG; Kim KS; Kim MG; Son S; Koo H; Kwon IC; Jeong JH; Jeong SY; Kim SH; Kim K
J Control Release; 2015 Jan; 198():1-9. PubMed ID: 25481438
[TBL] [Abstract][Full Text] [Related]
20. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
